One of the participating institutions should have access to Biosafety Level 3 and above facilities, along with expertise of handling respiratory viruses as per WHO/Govt. of India protocols.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.